Page last updated: 2024-09-05

solifenacin succinate and Adverse Drug Event

solifenacin succinate has been researched along with Adverse Drug Event in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W1
Chyou, TY; Nicholls, C; Nishtala, PS1
Khalil, MT; Mansoor, SN; Shafiq, O; Younas, U1
Hussar, DA1
Cardozo, L; Castro-Diaz, D; Gittelman, M; Huang, M; Ridder, A1

Trials

1 trial(s) available for solifenacin succinate and Adverse Drug Event

ArticleYear
Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin.
    International urogynecology journal and pelvic floor dysfunction, 2006, Volume: 17, Issue:5

    Topics: Adult; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Muscarinic Antagonists; Population; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence

2006

Other Studies

4 other study(ies) available for solifenacin succinate and Adverse Drug Event

ArticleYear
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011
Analysis of the nervous system and gastrointestinal adverse events associated with solifenacin in older adults using the US FDA adverse event reporting system.
    The International journal of risk & safety in medicine, 2023, Volume: 34, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Aged; Bayes Theorem; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Muscarinic Antagonists; Pharmacovigilance; Solifenacin Succinate; United States; United States Food and Drug Administration

2023
Solifenacin-induced acute urticaria and angioedema: a rare adverse effect.
    Postgraduate medical journal, 2022, Volume: 98, Issue:1160

    Topics: Adult; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Drug-Related Side Effects and Adverse Reactions; Humans; Iatrogenic Disease; Male; Solifenacin Succinate; Tongue Diseases; Urticaria

2022
New drugs 06, part I.
    Nursing, 2006, Volume: 36, Issue:2

    Topics: Acamprosate; Adenine Nucleotides; Alcohol Deterrents; Amyloid; Analgesics, Non-Narcotic; Anti-HIV Agents; Antifungal Agents; Antineoplastic Agents; Aptamers, Nucleotide; Arabinonucleosides; Azabicyclo Compounds; Benzofurans; Clofarabine; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Exenatide; Fibroblast Growth Factor 7; Guanine; Humans; Hypoglycemic Agents; Islet Amyloid Polypeptide; Lipopeptides; Lipoproteins; Macular Degeneration; Micafungin; omega-Conotoxins; Patient Education as Topic; Peptides; Peptides, Cyclic; Piperazines; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Stomatitis; Taurine; Tetrahydroisoquinolines; Urinary Incontinence; Venoms

2006